Pharma

Your Article Summary

See Latest Articles

FDA Advisory Committee Recommends Approval for Use of GARDASIL in Boys and Men
Merck & Co., 09/10/09

Merck & Co., Inc. announced that the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus types 6 and 11.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

 See all of Drug/Product Approvals

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Tricare contracts may be re-bid after losing plans protest
American Medical News , 11/25/09

GSK Regulatory Update: Avodart
GlaxoSmithKline, 11/24/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

 See all of Regulatory Issues